导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -13.02% | 880/1050 |
| 近一周 | -2.68% | 864/1104 |
| 近一月 | -2.24% | 399/1103 |
| 近一季 | 1.32% | 233/1092 |
| 近半年 | -11.70% | 822/1070 |
| 近一年 | -23.75% | 946/1018 |
| 近两年 | -5.24% | 902/926 |
| 近三年 | -42.89% | 826/834 |
| 成立以来 | -6.06% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.40% 880/1070 |
-10.76% 930/1101 |
- - |
- - |
| 2025 | -12.41% 962/1065 |
-1.89% 904/1014 |
-10.51% 1000/1038 |
7.26% 895/1050 |
-6.99% 802/1065 |
| 2024 | -14.50% 847/1011 |
-6.63% 641/960 |
-13.07% 926/983 |
15.38% 210/991 |
-8.70% 853/1011 |
| 2023 | -13.56% 458/952 |
10.34% 106/880 |
-16.64% 866/895 |
3.80% 9/915 |
-9.47% 836/952 |
| 2022 | -18.33% 267/867 |
-23.31% 681/773 |
19.39% 26/806 |
-15.62% 600/845 |
5.71% 173/867 |
| 2021 | -15.22% 516/740 |
-4.78% 332/580 |
8.03% 409/659 |
-14.64% 602/704 |
-3.45% 553/740 |
| 2020 | 75.93% 110/554 |
-0.97% 184/419 |
27.41% 154/466 |
17.94% 80/517 |
18.22% 147/554 |
| 2019 | 43.11% 197/410 |
29.75% 386/1146 |
5.78% 35/1228 |
-0.03% 333/390 |
4.31% 357/410 |
| 2018 | - - |
- - |
-1.69% 110/990 |
-2.48% 331/1000 |
-11.21% 421/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 长信消费精选量化股票A VS. 东吴新产业精选股票A(580008) |